Emtora Biosciences Overview
- Year Founded
-
2012
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$16.9M
- Investors
-
4
Emtora Biosciences General Information
Description
Developer of novel therapeutics designed to prevent the onset and recurrence of cancer. The company creates a novel formulation of rapamycin that slows down the aging process, regenerates the immune system, and prevents cancer progression, enabling medical practitioners to treat patients suffering from cancer.
Contact Information
Website
www.emtorabio.comCorporate Office
- 16601 Blanco Road
- Suite 120
- San Antonio, TX 78232
- United States
Corporate Office
- 16601 Blanco Road
- Suite 120
- San Antonio, TX 78232
- United States
Emtora Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Grant | 17-Aug-2022 | $16.9M | Completed | Clinical Trials - Phase 3 | ||
| 9. Grant | 01-Jan-2022 | Completed | Clinical Trials - Phase 3 | |||
| 8. Grant | 26-Aug-2019 | Completed | Clinical Trials - Phase 2 | |||
| 7. Later Stage VC (Series A1) | 09-Aug-2019 | Completed | Clinical Trials - Phase 2 | |||
| 6. Later Stage VC | 16-Feb-2018 | Cancelled | Clinical Trials - Phase 1 | |||
| 5. Later Stage VC (Series B) | 07-Aug-2017 | Completed | Clinical Trials - Phase 1 | |||
| 4. Early Stage VC | Completed | Clinical Trials - Phase 1 | ||||
| 3. Early Stage VC | 18-Apr-2016 | Cancelled | Clinical Trials - Phase 1 | |||
| 2. Early Stage VC (Series A) | 02-Jun-2015 | $3.93M | $3.93M | Completed | Clinical Trials - Phase 1 | |
| 1. Early Stage VC | 09-Jul-2013 | Completed | Clinical Trials - Phase 1 |
Emtora Biosciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-1 | ||||||||
| Series A |
Emtora Biosciences Comparisons
Industry
Financing
Details
Emtora Biosciences Competitors (63)
One of Emtora Biosciences’s 63 competitors is Immetas, a Venture Capital-Backed company based in East Hanover, NJ.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Immetas | Venture Capital-Backed | East Hanover, NJ | ||||
| Centrose | Venture Capital-Backed | Madison, WI | ||||
| Apexian Pharmaceuticals | Venture Capital-Backed | Indianapolis, IN | ||||
| Rein Therapeutics | Formerly VC-backed | Austin, TX | ||||
| ImmunOs Therapeutics | Venture Capital-Backed | Schlieren, Switzerland |
Emtora Biosciences Patents
Emtora Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3131546-A1 | Oral rapamycin preparation and use for stomatitis | Active | 16-Apr-2014 | ||
| EP-3131546-A4 | Oral rapamycin preparation and use for stomatitis | Active | 16-Apr-2014 | ||
| US-20170079962-A1 | Oral rapamycin preparation and use for stomatitus | Inactive | 16-Apr-2014 | ||
| EP-3131546-B1 | Oral rapamycin preparation for use in treating feline chronic gingivo- stomatitis (fcgs) | Active | 16-Apr-2014 | ||
| US-20150202164-A1 | Oral rapamycin nanoparticle preparations | Active | 31-Dec-2013 | A61K31/436 |
Emtora Biosciences Signals
Emtora Biosciences Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| National Cancer Institute | Government | |||
| Cancer Prevention and Research Institute of Texas | Government | |||
| Barshop Ventures | Family Office | Minority | ||
| UT Horizon Fund | Venture Capital | Minority |
Emtora Biosciences FAQs
-
When was Emtora Biosciences founded?
Emtora Biosciences was founded in 2012.
-
Where is Emtora Biosciences headquartered?
Emtora Biosciences is headquartered in San Antonio, TX.
-
What is the size of Emtora Biosciences?
Emtora Biosciences has 3 total employees.
-
What industry is Emtora Biosciences in?
Emtora Biosciences’s primary industry is Drug Discovery.
-
Is Emtora Biosciences a private or public company?
Emtora Biosciences is a Private company.
-
What is Emtora Biosciences’s current revenue?
The current revenue for Emtora Biosciences is .
-
How much funding has Emtora Biosciences raised over time?
Emtora Biosciences has raised $24M.
-
Who are Emtora Biosciences’s investors?
National Cancer Institute, Cancer Prevention and Research Institute of Texas, Barshop Ventures, and UT Horizon Fund have invested in Emtora Biosciences.
-
Who are Emtora Biosciences’s competitors?
Immetas, Centrose, Apexian Pharmaceuticals, Rein Therapeutics, and ImmunOs Therapeutics are some of the 63 competitors of Emtora Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process